Narayana Hrudayalaya growth over the years

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Compounded a year	1 yr	3 yr
Revenue	+44.0%	+20.4%
EBITDA	+26.7%	+18.7%
Net Income	+1.9%	+9.9%
EPS (adj.)	+2.0%	+9.9%
Total Assets	+71.8%	+44.2%
Total Equity	+25.1%	+28.6%
Free Cash Flow	—	+9.7%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NH₹1,655.00

Narayana Hrudayalaya Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP MAXHEALTH FORTIS NEULANDLAB NATCOPHARM LALPATHLAB SAILIFE COHANCEMcap ₹33,822 Cr

Annuals · FY-end closes

Compounded Growth Annuals · CAGR %	1Y CAGR	3Y CAGR
Revenue	+44.0	+20.4
EBITDA	+26.7	+18.7
Net Income	+1.9	+9.9
EPS (adj.)	+2.0	+9.9
Total Assets	+71.8	+44.2
Total Equity	+25.1	+28.6
Free Cash Flow	—	+9.7

CAGR from filed annuals — needs positive start & end values.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.